610.00
0.00
(0.00%)
At close: April 9 at 4:40:41 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 27 | 25 |
| Avg. Estimate | 12.77B | 14.3B | 59.51B | 71.46B |
| Low Estimate | 12.35B | 13.86B | 57.95B | 65.07B |
| High Estimate | 13.23B | 14.61B | 62.08B | 79.59B |
| Year Ago Sales | 8.77B | 11.3B | 45.04B | 59.51B |
| Sales Growth (year/est) | 45.63% | 26.50% | 32.13% | 20.07% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LLY.SW | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 4/14/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 4/9/2025 |
| Upgrade | Goldman Sachs: Neutral to Buy | 4/8/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/5/2025 |
| Maintains | Truist Securities: Buy to Buy | 2/3/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 1/28/2025 |